-
WHO Report: Aerosols Not Likely To Be Significant Source Of COVID-19 Transmission
After 239 scientists raised concerns about transmission by aerosolized particles, the World Health Organization has issued a brief on the role of aerosolized particles — and called for more research. -
Deirdre Barrett: The Bugs In Our Dreams Are Helping Us Process The Coronavirus In Our Waking World
Swarms of bugs have infested our dreams. We have COVID-19 to thank for that, Barrett says. -
New Clues To ALS And Alzheimer's From Physics
Structures inside healthy brain cells nimbly move from one state to the next to perform different functions. But in certain degenerative brain diseases, scientists now think, that process gets stuck. -
This Coronavirus Doesn't Change Quickly, And That's Good News For Vaccine Makers
A coronavirus vaccine could become ineffective if the virus were to undergo certain genetic changes. But so far, so good: Scientists see no evidence that's happening. -
NASA Names Headquarters After Mary Jackson, Its First Black Female Engineer
NASA’s Washington, D.C., headquarters will soon bear the name of Mary Jackson, the agency’s first African American female engineer and a driving force… -
Alzheimer's Researchers Go Back To Basics To Find The Best Way Forward
After a decade of failure in treating Alzheimer's with drugs, the National Institutes of Health is funding a five-year effort in Seattle to learn more about how the disease starts in the brain. -
All You Wanted To Know About Coronavirus Vaccine Science But Were Afraid To Ask
Some of the technology behind coronavirus vaccine development dates back to the first vaccines; other techniques are much newer. Here are eight top strategies scientists are pursuing. -
A Tale Of Two Pandemics: COVID-19 And Obesity
There’s another pandemic that’s making COVID-19 much worse: obesity. -
Final Tests Of Some COVID-19 Vaccines To Start Next Month
The first experimental COVID-19 vaccine in the U.S. is on track to begin a huge study next month. -
Could Pressure For COVID-19 Drugs Lead The FDA To Lower Its Standards?
The FDA has sped up its approval process for coronavirus treatments, creating a new division to expedite the regulatory process. But is safety being sidelined for speed?
